Abiraterone and volumetric modulated arc therapy for second recurrence of node-positive prostate cancer – a case report
A case report to analyse the role of abiraterone and volumetric-modulated arc therapy towards prostate cancer.
The Journal of Diagnostic Imaging in Therapy is dedicated to advancing the use of medical imaging in both diagnosis and treatment. It publishes research and clinical insights on X-ray, CT, MRI, ultrasound, and nuclear medicine techniques, highlighting how imaging supports patient management across a range of conditions. The journal features technological developments, applied case studies and discussion of practical and ethical considerations surrounding imaging practice. Sharing peer-informed analysis and clinical experience supports education and professional development among radiologists, clinicians, and imaging scientists. It also encourages collaboration by connecting researchers and practitioners working in related areas. Through critical discussion and evidence-based reporting, the journal contributes to improved standards, innovation and patient-centred care in diagnostic imaging and therapy.
A case report to analyse the role of abiraterone and volumetric-modulated arc therapy towards prostate cancer.
Neuroendocrine tumours include a spectrum of neoplasms characterized by histologic heterogeneity.
Neuroendocrine tumours include a spectrum of neoplasms characterized by histologic heterogeneity.
Automated radiosynthesis of fluorine-18 choline using a modified TracerLab module.
Radiotracer SCH442416 is used in a PET study and was found to selective for the A2A receptor.
PET radiotracer SCH442416 is the first nonxanthine radioligand suitable for in vivo imaging of adenosine A2A receptors.